Bio-Rad Laboratories Inc.

AI Score

XX

Unlock

234.97
-10.55 (-4.30%)
At close: Apr 03, 2025, 3:59 PM
234.75
-0.09%
After-hours: Apr 03, 2025, 04:05 PM EDT

Bio-Rad Laboratories Statistics

Share Statistics

Bio-Rad Laboratories has 27.98M shares outstanding. The number of shares has increased by -1.66% in one year.

Shares Outstanding 27.98M
Shares Change (YoY) -1.66%
Shares Change (QoQ) 0.31%
Owned by Institutions (%) 71%
Shares Floating 23.46M
Failed to Deliver (FTD) Shares 18
FTD / Avg. Volume 0.01%

Short Selling Information

The latest short interest is 662.32K, so 2.36% of the outstanding shares have been sold short.

Short Interest 662.32K
Short % of Shares Out 2.36%
Short % of Float 2.83%
Short Ratio (days to cover) 3.94

Valuation Ratios

The PE ratio is -5.03 and the forward PE ratio is 32.38. Bio-Rad Laboratories's PEG ratio is -0.03.

PE Ratio -5.03
Forward PE 32.38
PS Ratio 3.61
Forward PS 2.3
PB Ratio 1.41
P/FCF Ratio 34.82
PEG Ratio -0.03
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Bio-Rad Laboratories.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 2.58, with a Debt / Equity ratio of 0.03.

Current Ratio 2.58
Quick Ratio 2.58
Debt / Equity 0.03
Debt / EBITDA -0.08
Debt / FCF 0.65
Interest Coverage 5.5

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee $333.31K
Profits Per Employee $-239.51K
Employee Count 7,700
Asset Turnover 0.27
Inventory Turnover n/a

Taxes

Income Tax -498.3M
Effective Tax Rate 21.27%

Stock Price Statistics

The stock price has increased by -25.34% in the last 52 weeks. The beta is 0.98, so Bio-Rad Laboratories's price volatility has been higher than the market average.

Beta 0.98
52-Week Price Change -25.34%
50-Day Moving Average 288.57
200-Day Moving Average 317.07
Relative Strength Index (RSI) 36.92
Average Volume (20 Days) 296.07K

Income Statement

In the last 12 months, Bio-Rad Laboratories had revenue of 2.57B and earned -1.84B in profits. Earnings per share was -65.36.

Revenue 2.57B
Gross Profit 1.38B
Operating Income 269M
Net Income -1.84B
EBITDA -2.14B
EBIT -2.29B
Earnings Per Share (EPS) -65.36
Full Income Statement

Balance Sheet

The company has 0 in cash and 174.3M in debt, giving a net cash position of -174.3M.

Cash & Cash Equivalents 0
Total Debt 174.3M
Net Cash -174.3M
Retained Earnings 7.42B
Total Assets 9.36B
Working Capital 2.56B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 455.2M and capital expenditures -189M, giving a free cash flow of 266.2M.

Operating Cash Flow 455.2M
Capital Expenditures -189M
Free Cash Flow 266.2M
FCF Per Share 9.44
Full Cash Flow Statement

Margins

Gross margin is 53.73%, with operating and profit margins of 10.48% and -71.86%.

Gross Margin 53.73%
Operating Margin 10.48%
Pretax Margin -91.27%
Profit Margin -71.86%
EBITDA Margin -83.46%
EBIT Margin 10.48%
FCF Margin 10.37%

Dividends & Yields

BIO does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

The average price target for BIO is $417.5, which is 70.4% higher than the current price. The consensus rating is "Buy".

Price Target $417.5
Price Target Difference 70.4%
Analyst Consensus Buy
Analyst Count 4
Stock Forecasts

Stock Splits

The last stock split was on Mar 8, 2002. It was a forward split with a ratio of 2:1.

Last Split Date Mar 8, 2002
Split Type forward
Split Ratio 2:1

Scores

Altman Z-Score 1.58
Piotroski F-Score 6